257 related articles for article (PubMed ID: 24106728)
21. The diagnosis and treatment of minimal hepatic encephalopathy.
Zhan T; Stremmel W
Dtsch Arztebl Int; 2012 Mar; 109(10):180-7. PubMed ID: 22470407
[TBL] [Abstract][Full Text] [Related]
22. Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?
Quero Guillén JC; Groeneweg M; Jiménez Sáenz M; Schalm SW; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2002 Sep; 94(9):544-57. PubMed ID: 12587235
[TBL] [Abstract][Full Text] [Related]
23. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.
Sharma K; Pant S; Misra S; Dwivedi M; Misra A; Narang S; Tewari R; Bhadoria AS
Saudi J Gastroenterol; 2014; 20(4):225-32. PubMed ID: 25038208
[TBL] [Abstract][Full Text] [Related]
24. Minimal hepatic encephalopathy matters in daily life.
Bajaj JS
World J Gastroenterol; 2008 Jun; 14(23):3609-15. PubMed ID: 18595126
[TBL] [Abstract][Full Text] [Related]
25. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.
Bajaj JS; Thacker LR; Heuman DM; Fuchs M; Sterling RK; Sanyal AJ; Puri P; Siddiqui MS; Stravitz RT; Bouneva I; Luketic V; Noble N; White MB; Monteith P; Unser A; Wade JB
Hepatology; 2013 Sep; 58(3):1122-32. PubMed ID: 23389962
[TBL] [Abstract][Full Text] [Related]
26. Minimal Hepatic Encephalopathy in Indians: Psychometric Hepatic Encephalopathy Score and Inhibitory Control Test for Diagnosis and Rifaximin or Lactulose for Its Reversal.
Pawar VB; Surude RG; Sonthalia N; Zanwar V; Jain S; Contractor Q; Rathi PM
J Clin Transl Hepatol; 2019 Dec; 7(4):304-312. PubMed ID: 31915599
[No Abstract] [Full Text] [Related]
27. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
[TBL] [Abstract][Full Text] [Related]
28. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
Mittal VV; Sharma BC; Sharma P; Sarin SK
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
[TBL] [Abstract][Full Text] [Related]
29. Minimal hepatic encephalopathy.
Stewart CA; Smith GE
Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):677-85. PubMed ID: 18043677
[TBL] [Abstract][Full Text] [Related]
30. The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies.
Ridola L; Cardinale V; Riggio O
Ann Gastroenterol; 2018; 31(2):151-164. PubMed ID: 29507462
[TBL] [Abstract][Full Text] [Related]
31. Minimal hepatic encephalopathy: diagnosis by neuropsychological and neurophysiologic methods.
Kharbanda PS; Saraswat VA; Dhiman RK
Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S37-41. PubMed ID: 15025253
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.
Wang MW; Ma WJ; Wang Y; Ma XH; Xue YF; Guan J; Chen X
Front Microbiol; 2023; 14():1091167. PubMed ID: 37032856
[TBL] [Abstract][Full Text] [Related]
33. Novel computerized psychometric tests as primary screening tools for the diagnosis of minimal hepatic encephalopathy.
Luo M; Mu R; Liu JF; Bai FH
World J Clin Cases; 2020 Aug; 8(16):3377-3389. PubMed ID: 32913845
[TBL] [Abstract][Full Text] [Related]
34. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
Sharma P; Sharma BC
Saudi J Gastroenterol; 2012; 18(3):168-72. PubMed ID: 22626795
[TBL] [Abstract][Full Text] [Related]
35. Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy.
Han W; Zhang H; Han Y; Duan Z
Metab Brain Dis; 2020 Aug; 35(6):869-881. PubMed ID: 32495311
[TBL] [Abstract][Full Text] [Related]
36. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
37. Minimal hepatic encephalopathy: time to recognise and treat.
Dhiman RK; Chawla YK
Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
[TBL] [Abstract][Full Text] [Related]
38. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study.
Allampati S; Duarte-Rojo A; Thacker LR; Patidar KR; White MB; Klair JS; John B; Heuman DM; Wade JB; Flud C; O'Shea R; Gavis EA; Unser AB; Bajaj JS
Am J Gastroenterol; 2016 Jan; 111(1):78-86. PubMed ID: 26644276
[TBL] [Abstract][Full Text] [Related]
40. Critical flickering frequency test: a diagnostic tool for minimal hepatic encephalopathy.
Metwally MA; Biomy HA; Omar MZ; Sakr AI
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1030-1034. PubMed ID: 31274595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
